Export 700 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is D  [Clear All Filters]
2013
Eamvijarn, A., Gomes, N. M., Dethoup, T., Buaruang, J., et al. (2013). Bioactive meroditerpenes and indole alkaloids from the soil fungus Neosartorya fischeri (KUFC 6344), and the marine-derived fungi Neosartorya laciniosa (KUFC 7896) and Neosartorya tsunodae (KUFC 9213). Tetrahedron, 69(40), 8583 - 8591.
Do Sameiro-Faria, M., Ribeiro, S., Rocha-Pereira, P., Fernandes, J., et al. (2013). Body mass index and resistance to recombinant human erythropoietin therapy in maintenance hemodialysis patients. Renal Failure, 35(10), 1392 - 1398.
Louis, F., Bézier, A., Periquet, G., Ferras, C., et al. (2013). The bracovirus genome of the parasitoid wasp cotesia congregata is amplified within 13 replication units, including sequences not packaged in the particles. Journal of Virology, 87(17), 9649 - 9660.
Louis, F., Bézier, A., Periquet, G., Ferras, C., et al. (2013). The bracovirus genome of the parasitoid wasp cotesia congregata is amplified within 13 replication units, including sequences not packaged in the particles. Journal of Virology, 87(17), 9649 - 9660.
Frias, B., Allen, S., Dawbarn, D., Charrua, A., et al. (2013). Brain-derived neurotrophic factor, acting at the spinal cord level, participates in bladder hyperactivity and referred pain during chronic bladder inflammation. Neuroscience, 234, 88 - 102.
Ramos, E. M., Latourelle, J. C., Gillis, T., Mysore, J. S., et al. (2013). Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset. Neurogenetics, 14(3-4), 173 - 179.
Ramos, E. M., Latourelle, J. C., Gillis, T., Mysore, J. S., et al. (2013). Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset. Neurogenetics, 14(3-4), 173 - 179.
Barros, J., Damásio, J., Tuna, A., Alves, I., et al. (2013). Cerebellar ataxia, hemiplegic migraine, and related phenotypes due to a CACNA1A missense mutation: 12-year follow-up of a large portuguese family. JAMA Neurology, 70(2), 235 - 240.
Azevedo, L. F., Costa-Pereira, A., Mendonça, L., Dias, C. C., & Castro-Lopes, J. M. (2013). Chronic pain and health services utilization: Is there overuse of diagnostic tests and inequalities in nonpharmacologic treatment methods utilization?. Medical Care, 51(10), 859 - 869.
Kohlova, M., Ribeiro, S., Do Sameiro-Faria, M., Rocha-Pereira, P., et al. (2013). Circulating cell-free DNA levels in hemodialysis patients and its association with inflammation, iron metabolism, and rhEPO doses. Hemodialysis International, 17(4), 664 - 667.
Dias, C. C., Rodrigues, P. P., da Costa-Pereira, A., & Magro, F. (2013). Clinical prognostic factors for disabling Crohn's disease: A systematic review and meta-analysis. World Journal of Gastroenterology, 19(24), 3866 - 3871.
Ferreira, N., Santos, S. A. O., Domingues, M. R. M., Saraiva, M. J., & Almeida, M. R. (2013). Dietary curcumin counteracts extracellular transthyretin deposition: Insights on the mechanism of amyloid inhibition. Biochimica et Biophysica Acta - Molecular Basis of Disease, 1832(1), 39 - 45.
Castro, B. M., Fedorov, A., Hornillos, V., Delgado, J., et al. (2013). Edelfosine and miltefosine effects on lipid raft properties: Membrane biophysics in cell death by antitumor lipids. Journal of Physical Chemistry B, 117(26), 7929 - 7940.
Braunlin, E., Rosenfeld, H., Kampmann, C., Johnson, J., et al. (2013). Enzyme replacement therapy for mucopolysaccharidosis VI: Long-term cardiac effects of galsulfase (Naglazyme®) therapy. Journal of Inherited Metabolic Disease, 36(2), 385 - 394.
Braunlin, E., Rosenfeld, H., Kampmann, C., Johnson, J., et al. (2013). Enzyme replacement therapy for mucopolysaccharidosis VI: Long-term cardiac effects of galsulfase (Naglazyme®) therapy. Journal of Inherited Metabolic Disease, 36(2), 385 - 394.
Magro, F., Santos-Antunes, J., Albuquerque, A., Vilas-Boas, F., et al. (2013). Epstein-barr virus in inflammatory bowel disease-correlation with different therapeutic regimens. Inflammatory Bowel Diseases, 19(8), 1710 - 1716.
Earnshaw, W. C., Allshire, R. C., Black, B. E., Bloom, K., et al. (2013). Esperanto for histones: CENP-A, not CenH3, is the centromeric histone H3 variant. Chromosome Research, 21(2), 101 - 106.
Earnshaw, W. C., Allshire, R. C., Black, B. E., Bloom, K., et al. (2013). Esperanto for histones: CENP-A, not CenH3, is the centromeric histone H3 variant. Chromosome Research, 21(2), 101 - 106.
Earnshaw, W. C., Allshire, R. C., Black, B. E., Bloom, K., et al. (2013). Esperanto for histones: CENP-A, not CenH3, is the centromeric histone H3 variant. Chromosome Research, 21(2), 101 - 106.
Magro, F., Langner, C., Driessen, A., Ensari, A., et al. (2013). European consensus on the histopathology of inflammatory bowel disease. Journal of Crohn's and Colitis, 7(10), 827 - 851.
Ferreira, C., Rocha, F. A., Damas, A. M., & Martins, P. M. (2013). On growth rate hysteresis and catastrophic crystal growth. Journal of Crystal Growth.
Durão, J., & Gales, L. (2013). Guest diffusion in dipeptide crystals. CrystEngComm, 15(8), 1532 - 1535.
Petrakis, I., Mavroeidi, V., Stylianou, K., Andronikidi, E., et al. (2013). Hsf-1 affects podocyte markers NPHS1, NPHS2 and WT1 in a transgenic mouse model of TTRVal30Met-related amyloidosis. Amyloid, 20(3), 164 - 172.
Petrakis, I., Mavroeidi, V., Stylianou, K., Efthymiou, G., et al. (2013). Human TTRV30M localization within podocytes in a transgenic mouse model of transthyretin related amyloidosis: Does the environment play a role?. Transgenic Research, 22(1), 101 - 116.
Pereira, P. J. B., Royant, A., Panjikar, S., & De Sanctis, D. (2013). In-house UV radiation-damage-induced phasing of selenomethionine-labeled protein structures. Journal of Structural Biology, 181(2), 89 - 94.

Pages


Home | Site Map | Contacts | Credits | Privacy & Cookies | WHISTLEBLOWER CHANNEL | Intranet | Social Networks |


rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 226 074 900 | email: info@i3s.up.pt | © copyright 2010 ibmc